Aotus Nancymaae Model Predicts Human Immune Response to the Placental Malaria Vaccine Candidate VAR2CSA

Placental malaria vaccines (PMVs) are being developed to prevent severe sequelae of placental malaria (PM) in pregnant women and their offspring. The leading candidate vaccine antigen VAR2CSA mediates parasite binding to placental receptor chondroitin sulfate A (CSA). Despite promising results in small animal studies, recent human trials of the first two PMV candidates (PAMVAC and PRIMVAC) generated limited cross-reactivity and cross-inhibitory activity to heterologous parasites. Here we immunized Aotus nancymaae monkeys with three PMV candidates (PAMVAC, PRIMVAC and ID1-ID2a_M1010) adjuvanted with Alhydrogel, and exploited the model to investigate boosting of functional vaccine responses during PM episodes as well as with nanoparticle antigens. PMV candidates induced high levels of antigen-specific IgG with significant cross-reactivity across PMV antigens by enzyme-linked immunosorbent assay. Conversely, PMV antibodies recognized native VAR2CSA and blocked CSA adhesion of only homologous parasites and not of heterologous parasites. PM episodes did not significantly boost VAR2CSA antibody levels or serum functional activity; nanoparticle and monomer antigens alike boosted serum reactivity but not functional activities. Overall, PMV candidates induced functional antibodies with limited heterologous activity in Aotus monkeys, similar to responses reported in humans. The Aotus model appears suitable for preclinical downselection of PMV candidates and assessment of antibody boosting by PM episodes.

Citing Articles

Current approaches to malaria vaccines.

Duffy P Curr Opin Microbiol. 2022; 70:102227.

PMID: 36343566 PMC: 11127243. DOI: 10.1016/j.mib.2022.102227.

References

Nielsen M, Resende M, de Jongh W, Ditlev S, Mordmuller B, Houard S . The Influence of Sub-Unit Composition and Expression System on the Functional Antibody Response in the Development of a VAR2CSA Based Plasmodium falciparum Placental Malaria Vaccine. PLoS One. 2015; 10(9):e0135406. PMC: 4556615. DOI: 10.1371/journal.pone.0135406. View

Rogerson S, Hviid L, Duffy P, Leke R, Taylor D . Malaria in pregnancy: pathogenesis and immunity. Lancet Infect Dis. 2007; 7(2):105-17. DOI: 10.1016/S1473-3099(07)70022-1. View

Brolin K, Persson K, Wahlgren M, Rogerson S, Chen Q . Differential recognition of P. falciparum VAR2CSA domains by naturally acquired antibodies in pregnant women from a malaria endemic area. PLoS One. 2010; 5(2):e9230. PMC: 2821912. DOI: 10.1371/journal.pone.0009230. View

Stowers A, Kennedy M, Keegan B, Saul A, Long C, Miller L . Vaccination of monkeys with recombinant Plasmodium falciparum apical membrane antigen 1 confers protection against blood-stage malaria. Infect Immun. 2002; 70(12):6961-7. PMC: 133036. DOI: 10.1128/IAI.70.12.6961-6967.2002. View

Salanti A, Staalsoe T, Lavstsen T, Jensen A, Sowa M, Arnot D . Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A-adhering Plasmodium falciparum involved in pregnancy-associated malaria. Mol Microbiol. 2003; 49(1):179-91. DOI: 10.1046/j.1365-2958.2003.03570.x. View

Jones T, Obaldia 3rd N, Gramzinski R, Hoffman S . Repeated infection of Aotus monkeys with Plasmodium falciparum induces protection against subsequent challenge with homologous and heterologous strains of parasite. Am J Trop Med Hyg. 2001; 62(6):675-80. DOI: 10.4269/ajtmh.2000.62.675. View

Babakhanyan A, Fang R, Wey A, Salanti A, Sama G, Efundem C . Comparison of the specificity of antibodies to VAR2CSA in Cameroonian multigravidae with and without placental malaria: a retrospective case-control study. Malar J. 2015; 14:480. PMC: 4666123. DOI: 10.1186/s12936-015-1023-6. View

Janitzek C, Peabody J, Thrane S, Carlsen P, Theander T, Salanti A . A proof-of-concept study for the design of a VLP-based combinatorial HPV and placental malaria vaccine. Sci Rep. 2019; 9(1):5260. PMC: 6437161. DOI: 10.1038/s41598-019-41522-5. View

Gozalo A, Montoya E . Reproduction of the owl monkey (Aotus nancymai) (primates:Cebidae) in captivity. Am J Primatol. 2020; 21(1):61-68. DOI: 10.1002/ajp.1350210107. View

10.

Tsai C, Duggan P, Shimp Jr R, Miller L, Narum D . Overproduction of Pichia pastoris or Plasmodium falciparum protein disulfide isomerase affects expression, folding and O-linked glycosylation of a malaria vaccine candidate expressed in P. pastoris. J Biotechnol. 2005; 121(4):458-70. DOI: 10.1016/j.jbiotec.2005.08.025. View

11.

Doritchamou J, Teo A, Fried M, Duffy P . Malaria in pregnancy: the relevance of animal models for vaccine development. Lab Anim (NY). 2017; 46(10):388-398. PMC: 6771290. DOI: 10.1038/laban.1349. View

12.

Baruch D, Pasloske B, Singh H, Bi X, Ma X, Feldman M . Cloning the P. falciparum gene encoding PfEMP1, a malarial variant antigen and adherence receptor on the surface of parasitized human erythrocytes. Cell. 1995; 82(1):77-87. DOI: 10.1016/0092-8674(95)90054-3. View

13.

Magistrado P, Minja D, Doritchamou J, Ndam N, John D, Schmiegelow C . High efficacy of anti DBL4ɛ-VAR2CSA antibodies in inhibition of CSA-binding Plasmodium falciparum-infected erythrocytes from pregnant women. Vaccine. 2010; 29(3):437-43. DOI: 10.1016/j.vaccine.2010.10.080. View

14.

Vanda K, Bobbili N, Matsunaga M, Chen J, Salanti A, Leke R . The Development, Fine Specificity, and Importance of High-Avidity Antibodies to VAR2CSA in Pregnant Cameroonian Women Living in Yaoundé, an Urban City. Front Immunol. 2021; 12:610108. PMC: 7953046. DOI: 10.3389/fimmu.2021.610108. View

15.

Fowkes F, McGready R, Cross N, Hommel M, Simpson J, Elliott S . New insights into acquisition, boosting, and longevity of immunity to malaria in pregnant women. J Infect Dis. 2012; 206(10):1612-21. PMC: 3475637. DOI: 10.1093/infdis/jis566. View

16.

Tuikue Ndam N, Fievet N, Bertin G, Cottrell G, Gaye A, Deloron P . Variable adhesion abilities and overlapping antigenic properties in placental Plasmodium falciparum isolates. J Infect Dis. 2004; 190(11):2001-9. DOI: 10.1086/425521. View

17.

Doritchamou J, Herrera R, Aebig J, Morrison R, Nguyen V, Reiter K . VAR2CSA Domain-Specific Analysis of Naturally Acquired Functional Antibodies to Plasmodium falciparum Placental Malaria. J Infect Dis. 2016; 214(4):577-86. PMC: 4957442. DOI: 10.1093/infdis/jiw197. View

18.

Obiakor H, Avril M, Macdonald N, Srinivasan P, Reiter K, Anderson C . Identification of VAR2CSA domain-specific inhibitory antibodies of the Plasmodium falciparum erythrocyte membrane protein 1 using a novel flow cytometry assay. Clin Vaccine Immunol. 2013; 20(3):433-42. PMC: 3592344. DOI: 10.1128/CVI.00638-12. View

19.

Foote J, Milstein C . Kinetic maturation of an immune response. Nature. 1991; 352(6335):530-2. DOI: 10.1038/352530a0. View

20.

Jaworowski A, Fernandes L, Yosaatmadja F, Feng G, Mwapasa V, Molyneux M . Relationship between human immunodeficiency virus type 1 coinfection, anemia, and levels and function of antibodies to variant surface antigens in pregnancy-associated malaria. Clin Vaccine Immunol. 2009; 16(3):312-9. PMC: 2650867. DOI: 10.1128/CVI.00356-08. View